Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination benzoyl peroxide/clindamycin gel and tazarotene cream for acne vulgaris
2015-004900-44Phase 2
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benzoyl peroxide, clindamycin and tazarotene in acne vulgaris (2 arms), sponsored by GSK. Primary endpoints: Absolute change in lesion counts from baseline to week 12 and ISGA 2-grade improvement by week 12.
02
Drugs
benzoyl peroxideclindamycintazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-004900-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004900-44.